1型糖尿病中的免疫逃避性β细胞:基因工程,生物材料和计算建模方面的创新
Ismail Can Karaoglu1, Doğukan Duymaz1, Mudassir M Rashid2
1Chemical and Biological Engineering, Koc University, Istanbul, Türkiye.
Frontiers in immunology
|September 4, 2025
概括
基因工程,生物材料和机器学习的进步为1型糖尿病 (T1D) 治疗提供了新的希望,通过改进β细胞替代疗法和克服免疫排斥以获得更好的移植生存.
科学领域:
- 复原医学
- 免疫学
- 生物技术
背景情况:
- 1型糖尿病 (T1D) 涉及自身免疫性破坏胰岛素生成的β细胞,需要终身胰岛素治疗而没有最终治愈.
- 目前的β细胞替代策略面临挑战,包括免疫排斥,有限的供体供应和长期不良的移植功能.
研究的目的:
- 审查基因工程,生物材料和机器学习的前沿进展,以提高T1D中的β细胞疗法.
- 探索克服免疫障碍并改善β细胞替代的临床可行性.
主要方法:
- 对基于CRISPR/Cas9的基因编辑创建低免疫性β细胞的最新创新进行审查.
- 讨论纳米,微和宏尺度生物材料封装系统的移植保护和整合.
- 在优化治疗结果和个性化治疗方面分析机器学习和计算建模应用.
主要成果:
- 像CRISPR/Cas9这样的基因编辑技术在产生免疫逃生β细胞方面表现有前途.
- 先进的生物材料提供物理和生化保护, 增强移植的生存和整合.
- 机器学习有助于预测治疗反应,并为个别患者量身定制治疗.
结论:
- 结合遗传,生物材料和计算策略的综合方法对于开发耐用,可扩展和免疫耐受性β细胞替代疗法至关重要.
- 目前正在进行的临床试验为转化环境提供了有价值的见解,突出了T1D治疗的成功和持续挑战.
更多相关视频
10:09Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
9.6K
09:31Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
7.3K
相关概念视频
Insulin: Biosynthesis, Chemistry, and Preparation
516
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
516
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Insulin Secretory Vesicles
5.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.4K
EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
